Halozyme Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2017
Total Assets: $519.9M
Liabilities Breakdown FY2017
Total Liabilities: $311.6M
Asset Breakdown
Total Assets: $519.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $168.7M | 32.5% |
| Accounts Receivable | $22.1M | 4.3% |
| Inventory | $5.1M | 1.0% |
| Property, Plant & Equipment | $3.5M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $320.4M | 61.6% |
Liabilities Breakdown
Total Liabilities: $311.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.9M | 2.6% |
| Long-Term Debt | $125.1M | 40.2% |
| Other Liabilities | $178.5M | 57.3% |